Early phase clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with RET fusion-positive cancers, high-grade (HGG) and low-grade glioma (LGG) and ovarian cancer. The results, presented today at the virtual American Association for Cancer […]
The University of Texas MD Anderson Cancer Center
Mutant KRAS and p53 Cooperate To Drive Pancreatic Cancer Metastasis
Preclinical research identifies CREB1 as new therapeutic target downstream of frequently mutated genes Researchers at The University of Texas MD Anderson Cancer Center have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact through the CREB1 protein […]
MD Anderson Researchers Recognized by AACR
Junior investigators Nicholas Navin, Ph.D., Kaysia Ludford, M.D., and Moran Amit, M.D., Ph.D., receive awards for cancer research Three researchers from The University of Texas MD Anderson Cancer Center have been honored by the American Association for Cancer Research (AACR) and will give virtual […]
MD Anderson’s Guillermina Lozano Elected to Fellows of the AACR Academy
Guillermina (Gigi) Lozano, Ph.D., chair of Genetics at The University of Texas MD Anderson Cancer Center, has been elected to the 2021 class of Fellows of the American Association for Cancer Research (AACR) Academy in recognition of her pioneering work to describe the […]
Collagen plays protective role during pancreatic cancer development
Findings suggest the protein helps slow tumor progression, pointing to new cancer therapeutic strategies Contrary to long-held beliefs, Type I collagen produced by cancer-associated fibroblasts may not promote cancer development but instead plays a protective role in controlling pancreatic cancer progression, reports […]
